Table 3:
aOR (95%CI)c | Change in BICd | NRI (SE)e | NRI (event) |
NRI (non-event) |
IDI (95% CI)f | Relative IDIg | |
---|---|---|---|---|---|---|---|
FEV1, per 10% | 1.00 (0.96–1.004) | 9.2 | 0.005 (0.005) | 0.003 | −0.002 | 0.00001 (−0.0001–0.0001) | 0.5% |
GOLD | 0.99 (0.90–1.08) | 23.7 | 0.020 (0.014) | −0.054 | −0.074 | −0.0001 (−0.0009–0.0006) | 2.3% |
Emphysema ≥ 5% | 1.13 (0.88–1.46) | 18.0 | 0.027 (0.012)a | −0.029 | −0.056 | 0.001 (0.0003–0.002)b | 12.8% |
Inhaled steroids | 0.99 (0.77–1.26) | 14.4 | −0.001 (0.006) | 0.005 | 0.006 | −0.0003 (−0.0029 – −0.0027)b | −3.1% |
6-minute walk distance, per 30 meters | 0.999 (0.998–0.9996)b | −9.6 | 0.043 (0.015)b | 0.014 | −0.029 | 0.001 (0.0001–0.002)a | 6.3% |
Modified Medical Research Council | 1.01 (0.94–1.09) | 0.1 | −0.002 (0.005) | −0.003 | −0.0005 | −0.0001 (−0.001–0.001) | −0.2% |
Total exacerbations | 1.11 (1.08–1.15)b | −30.8 | 0.026 (0.016) | −0.028 | −0.054 | 0.008 (0.003–0.013)b | 34.6% |
P <0.05
P<0.01
Adjusted Odds ratio (95% CI) for traditional risk factors (age enrollment, race, osteoporosis, prevalent hip or compression fracture, rheumatoid arthritis, diabetes).
Bayesian Information Criteria
Net reclassification index, using a category of 3.0%
Integrated discrimination improvement
Model slope with traditional predictors was 0.0229